期刊文献+

胃肠道平滑肌肿瘤微血管密度的测定及其临床意义 被引量:3

Determination and clinical significance of microvessel density in gastrointestinal smooth muscle tumors
原文传递
导出
摘要 目的 探讨微血管密度 (MVD)与胃肠道平滑肌肿瘤 (GISMT)良恶性、恶性程度、转移及预后的关系。 方法 采用免疫组织化学S P法检测 86例GISMT中MVD。 结果 MVD按平滑肌瘤、低度恶性平滑肌肉瘤、高度恶性平滑肌肉瘤的顺序依次明显增高 ,差异有非常显著性意义 (P <0 0 1)。同时 ,MVD与肿瘤良恶性生长方式、肿瘤大小、肿瘤中心有无坏死亦有明显关系 ,差异有非常显著性意义 (P <0 0 1)。MVD低表达组的 5年生存率明显高于高表达组 ,差异有非常显著性意义 (P<0 0 1)。 结论 MVD是反映GISMT生物学特性的良好标志物 ,其测定可以作为判断GISMT良恶性、恶性程度。 ObjectiveTo determine the relationship between microvessel density (MVD) and their benigncy or malignancy of gastrointestinal smooth muscle tumors (GISMT) metastasis, and prognosis. [WT5”HZ]Methods[WT5”BZ] 86 cases of GISMT were studied by immunochemical staining S P method for MVD. [WT5”HZ]Results[WT5”BZ] The count of MVD increased significantly according to the following order: leiomyomas, lower malignant leiomyoscarcomas, and higher malignant leiomyosarcomas ( P <0 01). The count of MVD was significantly assoiated with the tumors with or without contiguous organ invasion or distant metastasis, tumor size, and centre necrosis ( P <0 01).The 5 year survival rates were significantly higher in patients with low expression of MVD than those with high expression of MVD ( P <0 01). [WT5”HZ]Conclusions[WT5”BZ] MVD is a valuable indicator for biological characteristics of GISMT, and it can be used as an objective parameter for distinguishing maligant from benign tumor, judging malignancy, and predicting the prognosis of patients with GISMT.
出处 《中华外科杂志》 CAS CSCD 北大核心 2001年第4期305-307,共3页 Chinese Journal of Surgery
基金 辽宁省科委自然科学基金资助!(972 2 5 4)
关键词 胃肠肿瘤 平滑肌瘤 平滑肌肉瘤 微血管密度 MVD GISMT Gastrointestinal neoplasms Leiomyoma Leiomyoscarcoma Microvessel density
  • 相关文献

参考文献1

共引文献1

同被引文献19

  • 1李益农.小肠出血的诊断方法[J].中华消化杂志,1996,16(2):63-64. 被引量:54
  • 2[1]Folkman J.Fighting cancer by attacking its blood supply[J]. Sci Am,1996,275(3):150-154.
  • 3[3]Weidner N. Current pathologic methods for measuring intrarumoral microvessel density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat, 1995,36(2):169-180.
  • 4[4]McNamara DA,Harmey JH,Walsh TN et al.Significance of angiogenesis in cancer therapy (Review)[J].Br J Surg,1998,85(8):1044-1055.
  • 5[5]O'Byrne KJ,Dalgleish AG,Browning MJ et al.The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease (Review)[J].Eur J Cancer,2000,36(2):151-169.
  • 6[6]Brem S,Cotran R,Folkman J.Tumor angiogenesis: a quantitative method for histologic grading[J].J Natl Cancer Inst,1972,48(2):347-356.
  • 7[10]Schirner M,Hoffmann J, Menrad A et al.Antiangiogenic chemotherapeutic agents:characterijation in comperion to their tumor growth inhibition in human renal cell carcinoma models[J].Clin Cancer Res,1998,4(5):1331-1336.
  • 8[11]Makris A,Powles TJ,Kakolyris S et al. Raduction in augiogenesis after neoadjuvant chemoedocrine therapy in patients with operable breast carcinoma[J].Cancer,1999,85(9):1996-2000.
  • 9[2]Akwari OE.Leiomyosarcoma of the small intestine and large bowel.Cancer,1 978,42(6)∶1375-1384.
  • 10王绍林,王全华.原发性肝癌肝动脉栓塞治疗前后肿瘤血管的血流动力学改变[J].临床医学影像杂志,1997,8(1):43-45. 被引量:3

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部